DEA Reschedules Hydrocodone Combination Products

Posted in Latest News on September 9, 2014.

On Friday, August 22nd, the U. S. Drug Enforcement Administration (DEA) published a Final Rule moving hydrocodone combination products (HCPs) from Schedule III to the more-restrictive Schedule II. This Final Rule imposes the regulatory controls and sanctions applicable to Schedule II substances on those who handle or propose to handle HCPs. The rule goes into effect 45 days from its publish date.



More Latest News

Registration Renewal by Resident Physicians, Interns, and Fellows
May 4, 2017

Registrations expire on June 30, 2017, Ready to Renew? Click here for information for renewing your registration. Continue reading


Special Telephonic meeting with Board of Optometry
May 3, 2017

Attention: The Board of Optometry will be holding a special telephone meeting on May 11th, at 9:00 AM… Continue reading